CXCL8 and neoplasm: Increased plasma levels of IL-8 are associated with a single-nucleotide polymorphism (SNP) in IL-8 at 251 bp upstream [263], with the IL-8T–251A polymorphism being individually associated with tumor reappearance risk [264].